Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Change in Intangibles: 2023-2025

Historic Change in Intangibles for Adma Biologics (ADMA) over the last 1 years, with Jun 2025 value amounting to $105,000.

  • Adma Biologics' Change in Intangibles fell 64.88% to $105,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $159,000, marking a year-over-year change of. This contributed to the annual value of $349,000 for FY2024, which is 66.19% up from last year.
  • Latest data reveals that Adma Biologics reported Change in Intangibles of $105,000 as of Q2 2025, which was up 452.63% from $19,000 recorded in Q1 2025.
  • In the past 5 years, Adma Biologics' Change in Intangibles ranged from a high of $299,000 in Q2 2024 and a low of -$7,000 during Q4 2024.
  • Its 3-year average for Change in Intangibles is $97,571, with a median of $42,000 in 2024.
  • Its Change in Intangibles has fluctuated over the past 5 years, first plummeted by 103.33% in 2024, then rose by 26.67% in 2025.
  • Adma Biologics' Change in Intangibles (Quarterly) stood at $210,000 in 2023, then slumped by 103.33% to -$7,000 in 2024, then slumped by 64.88% to $105,000 in 2025.
  • Its Change in Intangibles was $105,000 in Q2 2025, compared to $19,000 in Q1 2025 and -$7,000 in Q4 2024.